Page last updated: 2024-08-16

rivastigmine and Body Weight

rivastigmine has been researched along with Body Weight in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's1 (11.11)29.6817
2010's7 (77.78)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, X; Chen, Y; Liu, BF; Liu, X; Qiu, Y; Xu, X; Yu, M; Zhang, G; Zhang, L; Zhang, Y1
Bando, N; Hirano, T; Ishikawa, I; Matsumoto, Y; Mori, I; Mori, T; Nakamura, Y; Park, H; Tanaka, M; Tsuno, N1
Mishra, DN; Nagpal, K; Singh, SK1
Isik, AT; Soysal, P1
Basaure, P; Cabré, M; Colomina, MT; Peris-Sampedro, F; Reverte, I1
Hisatsune, T; Matsuda, T1
Abdel-Aal, RA; Assi, AA; Kostandy, BB1
Bellucci, A; Casamenti, F; Costagli, C; Pepeu, G; Scali, C; Schmidt, B1
Hariguchi, S; Niigawa, H; Nishimura, T; Takeda, M; Tanimukai, S1

Other Studies

9 other study(ies) available for rivastigmine and Body Weight

ArticleYear
Synthesis and Biological Evaluation of Fused Tricyclic Heterocycle Piperazine (Piperidine) Derivatives As Potential Multireceptor Atypical Antipsychotics.
    Journal of medicinal chemistry, 2018, 11-21, Volume: 61, Issue:22

    Topics: Animals; Antipsychotic Agents; Body Weight; Chemistry Techniques, Synthetic; Drug Design; Ether-A-Go-Go Potassium Channels; Heterocyclic Compounds; Memory; Mice; Piperazine; Rats; Schizophrenia; Structure-Activity Relationship; Tissue Distribution

2018
Efficacy of rivastigmine transdermal therapy on low food intake in patients with Alzheimer's disease: The Attitude Towards Food Consumption in Alzheimer's Disease Patients Revive with Rivastigmine Effects study.
    Geriatrics & gerontology international, 2019, Volume: 19, Issue:7

    Topics: Aged, 80 and over; Alzheimer Disease; Appetite; Attitude to Health; Body Weight; Cholinesterase Inhibitors; Cognitive Dysfunction; Eating; Female; Humans; Male; Mental Status and Dementia Tests; Rivastigmine; Severity of Illness Index; Transdermal Patch; Treatment Outcome

2019
Optimization of brain targeted chitosan nanoparticles of Rivastigmine for improved efficacy and safety.
    International journal of biological macromolecules, 2013, Volume: 59

    Topics: Amnesia; Animals; Behavior, Animal; Body Weight; Brain; Chitosan; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Evaluation, Preclinical; Factor Analysis, Statistical; Male; Maze Learning; Memory; Mice; Nanoparticles; Neuroprotective Agents; Phenylcarbamates; Polysorbates; Rats; Rivastigmine; Scopolamine; Treatment Outcome

2013
Effects of Acetylcholinesterase Inhibitors on Nutritional Status in Elderly Patients with Dementia: A 6-month Follow-up Study.
    The journal of nutrition, health & aging, 2016, Volume: 20, Issue:4

    Topics: Acetylcholinesterase; Activities of Daily Living; Aged; Body Mass Index; Body Weight; Cholinesterase Inhibitors; Dementia; Disease Progression; Donepezil; Eating; Female; Follow-Up Studies; Galantamine; Geriatric Assessment; Humans; Indans; Male; Nutrition Assessment; Nutritional Status; Piperidines; Polypharmacy; Retrospective Studies; Rivastigmine

2016
Two cholinesterase inhibitors trigger dissimilar effects on behavior and body weight in C57BL/6 mice: The case of chlorpyrifos and rivastigmine.
    Behavioural brain research, 2017, 02-01, Volume: 318

    Topics: Acetylcholinesterase; Animals; Body Weight; Brain; Chlorpyrifos; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Male; Maze Learning; Memory; Mice; Rivastigmine

2017
Cholinergic Modification of Neurogenesis and Gliosis Improves the Memory of AβPPswe/PSEN1dE9 Alzheimer's Disease Model Mice Fed a High-Fat Diet.
    Journal of Alzheimer's disease : JAD, 2017, Volume: 56, Issue:1

    Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Body Weight; Cells, Cultured; Cholinesterase Inhibitors; Conditioning, Psychological; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Gliosis; Humans; Insulin; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurogenesis; Neurons; Presenilin-1; Rivastigmine

2017
Rivastigmine reverses aluminum-induced behavioral changes in rats.
    European journal of pharmacology, 2011, Jun-01, Volume: 659, Issue:2-3

    Topics: Aluminum; Animals; Avoidance Learning; Behavior, Animal; Body Weight; Cholinesterase Inhibitors; Cholinesterases; Cognition; Dose-Response Relationship, Drug; Feces; Male; Maze Learning; Memory; Movement; Phenylcarbamates; Rats; Rats, Inbred WF; Reaction Time; Rivastigmine; Rotarod Performance Test; Swimming

2011
Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats.
    Journal of neural transmission (Vienna, Austria : 1996), 2002, Volume: 109, Issue:7-8

    Topics: Acetylcholine; Aging; Animals; Body Weight; Brain; Carbamates; Cerebral Cortex; Cholinesterase Inhibitors; Cholinesterases; Donepezil; Drug Administration Schedule; Hippocampus; Indans; Male; Muscarinic Antagonists; Phenylcarbamates; Piperidines; Pirenzepine; Rats; Rats, Inbred F344; Rivastigmine; Trichlorfon

2002
Effects of SDZ ENA 713, novel acetyl cholinesterase inhibitor, on learning of rats with basal forebrain lesions.
    Progress in neuro-psychopharmacology & biological psychiatry, 1995, Volume: 19, Issue:1

    Topics: Animals; Body Weight; Carbamates; Cholinesterase Inhibitors; Electric Stimulation; Learning; Locomotion; Phenylcarbamates; Prosencephalon; Rats; Rats, Wistar; Rivastigmine

1995